Strongyloides stercoralis for FRCPath Part 2 Medical Microbiology Life Cycle, Diagnosis, Treatment and Exam Tips
A patient with vague abdominal symptoms, intermittent eosinophilia, and a history of residence in the tropics may look like a routine parasitology question. Add corticosteroids, and the same infection can become fatal. That is why Strongyloides stercoralis is a high-yield organism for FRCPath Medical Microbiology Part 2: it links classic parasitology with immunosuppression, diagnostic limitations, laboratory communication, and urgent clinical management.
This article is for exam preparation and clinical revision. It is not a substitute for local guidelines, specialist infectious diseases advice, or patient-specific management.
Overview of the organism and why it matters in the exam
S. stercoralis is an intestinal nematode with one feature that makes it stand apart from many other helminths: autoinfection. The parasite can complete part of its life cycle within the human host, allowing infection to persist for decades after exposure.
That single fact explains much of its clinical importance:
Infection may present years after leaving an endemic region.
Stool microscopy can be negative despite true infection.
Eosinophilia may be absent in severe disseminated disease.
Corticosteroids can trigger hyperinfection, even after short courses.
Screening matters before transplantation, chemotherapy, biological therapy, and prolonged steroids.
The disease caused by the parasite is called Strongyloidosis. It ranges from asymptomatic carriage to life-threatening hyperinfection and dissemination.
Epidemiologically, infection is most common in tropical and subtropical regions, especially where sanitation is poor and people have direct skin contact with contaminated soil. Cases seen in the UK often relate to previous residence or travel in endemic areas, migration, military service, or immunosuppression in someone with remote exposure.
For Part 2, the organism is attractive because it tests both knowledge and judgement. A good answer should not stop at naming the parasite. It should show awareness of clinical risk, appropriate tests, communication with the requesting team, and treatment urgency.
Life cycle and transmission
The life cycle is the core of this topic. If it is clear, the presentations and exam questions become much easier.
The standard parasitic cycle
Adult female worms live in the mucosa of the small intestine, mainly the duodenum and jejunum. Unlike many intestinal nematodes, parasitic adult males are not usually involved in the human intestinal phase. The females produce eggs by parthenogenesis.
The eggs hatch in the intestinal mucosa, releasing rhabditiform larvae. These are the larvae typically passed in stool.
Once in the environment, rhabditiform larvae may follow one of two routes:
Develop directly into infective filariform larvae.
Develop into free-living adult male and female worms in soil, which reproduce and generate more larvae.
The infective stage is the filariform larva. It penetrates intact skin, usually through bare feet or other exposed skin in contact with contaminated soil.
After skin penetration, larvae enter the circulation, travel to the lungs, break into the alveoli, ascend the bronchial tree, reach the pharynx, and are swallowed. They then mature into adult female worms in the small intestine.
This lung migration can produce respiratory symptoms in some patients, and it explains why larvae may be found in sputum or bronchoalveolar lavage during hyperinfection.
Autoinfection is the defining feature
Autoinfection occurs when rhabditiform larvae transform into infective filariform larvae before leaving the host. This can happen:
Within the intestine.
On perianal skin after larvae are passed.
The filariform larvae then penetrate the intestinal mucosa or perianal skin and re-enter the circulation. The cycle continues without fresh environmental exposure.
This is the reason infection may persist for many years. It also explains why an elderly patient in a non-endemic country may still develop severe disease after receiving steroids decades after the original exposure.
A useful exam phrase is:
Autoinfection allows chronic persistence and creates the risk of hyperinfection when cell-mediated immunity is impaired.
Hyperinfection and dissemination
Hyperinfection means acceleration of the normal autoinfective cycle, with large numbers of larvae moving through the gut and lungs. Disseminated disease means larvae spread beyond the usual pulmonary and gastrointestinal routes, for example to the central nervous system, liver, or other organs.
The distinction is useful, but in real clinical practice both demand urgent treatment. Both are associated with high mortality, especially when diagnosis is delayed.
Risk factors include:
Corticosteroid therapy.
Human T-cell lymphotropic virus type 1 infection.
Haematological malignancy.
Solid organ or stem cell transplantation.
Other significant immunosuppression.
Malnutrition and severe chronic illness.
Corticosteroids are particularly important in exam questions. They impair immune control and may also have direct effects that favour larval development. Severe disease can occur after relatively short exposure in a chronically infected person.
Main routes of transmission
The classic route is skin penetration by filariform larvae in contaminated soil. This is the key route to remember.
Other routes are less common but important in clinical microbiology:
Transmission through organ transplantation from an infected donor.
Transmission through infected tissue in rare circumstances.
Perinatal or breast milk transmission has been described rarely, but it is not the standard exam answer.
Person-to-person spread through ordinary contact does not usually occur. The parasite needs larval development, and transmission relates to contaminated soil or infected donor material rather than casual contact.
Clinical manifestations and diagnostic methods
Clinical disease varies widely. A structured answer should separate chronic uncomplicated infection from hyperinfection and disseminated disease.
Chronic uncomplicated infection
Many patients are asymptomatic. When symptoms occur, they are often non-specific.
Gastrointestinal features may include:
Intermittent abdominal pain.
Diarrhoea or alternating bowel habit.
Nausea.
Weight loss.
Malabsorption in heavier infection.
Skin features may include:
Pruritic rash at the site of larval penetration.
Urticaria.
Larva currens, a rapidly moving, serpiginous, itchy rash, often around the buttocks, groin, or trunk.
Respiratory features may occur during larval migration:
Cough.
Wheeze.
Transient pulmonary infiltrates.
Symptoms that resemble asthma or allergic disease.
Laboratory clues include eosinophilia and raised IgE. Eosinophilia can be intermittent, so a normal eosinophil count does not exclude infection.
Hyperinfection syndrome
Hyperinfection usually presents with worsening gastrointestinal and pulmonary disease due to increased larval burden along the normal migration pathway.
Possible features include:
Severe abdominal pain.
Ileus or bowel obstruction-like features.
Gastrointestinal bleeding.
Severe diarrhoea.
Cough, haemoptysis, wheeze, or respiratory failure.
Diffuse pulmonary infiltrates.
A major complication is Gram-negative sepsis. Migrating larvae can carry enteric bacteria across the bowel wall and into the bloodstream. This can lead to bacteraemia, meningitis, or severe sepsis with organisms such as Enterobacterales. In an exam scenario, Gram-negative meningitis plus larvae in sputum or stool in an immunosuppressed patient is a strong clue.
Disseminated disease
Dissemination involves larvae outside the usual gut-lung cycle. Presentations include:
Meningitis or encephalitis.
Hepatic involvement.
Widespread skin lesions.
Multi-organ failure.
Polymicrobial sepsis.
Eosinophilia is often absent in severe disease, especially in patients on steroids. This is a common exam trap. Do not exclude severe strongyloid infection because the eosinophil count is normal.
Diagnosis in the laboratory and clinic
No single test is perfect. The best approach depends on the clinical syndrome and the urgency of the situation.
Stool microscopy
Traditional stool microscopy may detect rhabditiform larvae. Eggs are not usually the main finding in stool because they hatch in the intestinal mucosa before passage.
A key limitation is low sensitivity in chronic infection. Larval output can be scanty and intermittent. A single negative stool does not exclude infection.
To improve yield, laboratories may use:
Multiple stool samples collected on different days.
Concentration methods.
Baermann technique.
Agar plate culture.
Agar plate culture can be sensitive because larvae create visible tracks as they move across the plate. The trade-off is that it requires expertise and careful handling.
Serology
Serology is useful for screening and chronic infection. IgG antibody detection is often more sensitive than a single stool examination, especially when larval output is low.
Limitations include:
Cross-reactivity with other helminths.
Reduced sensitivity in some immunocompromised patients.
Inability to reliably distinguish active from past infection in all cases.
Slow decline after treatment, which can make early post-treatment interpretation difficult.
In a Part 2 answer, serology is often the right screening test in a patient with epidemiological risk before immunosuppression. Positive results need clinical correlation and usually treatment.
Molecular tests
PCR assays may detect parasite DNA in stool, depending on local availability. They can improve sensitivity and specificity when validated, but access varies. In the exam, mention PCR as an adjunct where available, not as the sole universal test.
Respiratory and tissue specimens
In hyperinfection, larvae may be found in:
Sputum.
Bronchoalveolar lavage.
Gastric aspirate.
Duodenal aspirate.
Small bowel biopsy.
Occasionally other tissue or fluid samples in dissemination.
If larvae are seen in respiratory specimens, this is a medical emergency. The laboratory should contact the clinical team promptly.
Blood tests and imaging
Supportive findings include eosinophilia, raised IgE, anaemia, hypoalbuminaemia, or inflammatory markers, depending on severity. In hyperinfection, eosinophilia may disappear.
Chest imaging may show transient infiltrates in uncomplicated migration or diffuse infiltrates in severe disease. Abdominal imaging may show ileus, bowel wall thickening, or non-specific inflammatory changes. These findings support assessment but do not confirm the diagnosis.
Differentiating larvae in stool
Examiners may ask how to distinguish Strongyloides larvae from hookworm larvae.
Feature | S. stercoralis rhabditiform larva | Hookworm rhabditiform larva |
Buccal cavity | Short | Long |
Genital primordium | Prominent | Less prominent |
Usual stool finding | Larvae | Eggs in fresh stool, larvae may appear if stool is old |
Main exam point | Autoinfection possible | Autoinfection is not a usual feature |
This comparison is worth revising with images from a trusted parasitology atlas. Morphology is easier to remember visually than as text alone.
Treatment options and management strategies
Treatment decisions should account for disease severity, immune status, drug absorption, and the risk of dissemination.
Ivermectin is the treatment of choice
Ivermectin is widely regarded as first-line therapy for uncomplicated infection. Common regimens use oral ivermectin, often given as weight-based dosing. Exact dose and duration should follow national or local guidance, and specialist advice is appropriate for complicated cases.
For chronic uncomplicated infection, treatment is usually short course, with follow-up to document response. Many centres repeat stool testing if larvae were seen before treatment, and serology may be followed over time, although antibody levels can take months to fall.
Albendazole is an alternative but less effective
Albendazole has activity against the parasite but is generally considered less effective than ivermectin. It may be used when ivermectin is unavailable or contraindicated, guided by specialist advice.
Thiabendazole is historically important but poorly tolerated and not commonly used in many settings.
Hyperinfection needs urgent, active management
Hyperinfection and disseminated infection are emergencies. Management should include:
Urgent ivermectin therapy.
Daily or repeated treatment until clinical improvement and clearance of larvae, according to expert guidance.
Review and reduction of immunosuppression where feasible.
Investigation and treatment of Gram-negative sepsis.
Respiratory support if needed.
Repeat parasitological monitoring of stool, sputum, or other positive specimens.
Absorption can be poor in ileus, severe diarrhoea, or critical illness. Specialist centres sometimes consider alternative routes of ivermectin administration when oral absorption is not reliable, but this is an expert decision and may involve access issues.
Manage bacterial complications
Do not focus only on the helminth. Larval migration can carry gut flora into the bloodstream. Empirical antibacterial therapy may be needed in severe disease, especially with sepsis, meningitis, pneumonia, or shock. Blood cultures, cerebrospinal fluid studies, and imaging should be guided by the presentation.
Screen before immunosuppression
Preventing hyperinfection is safer than treating it late. Screening should be considered for people with epidemiological risk before:
Prolonged or high-dose corticosteroids.
Solid organ transplantation.
Stem cell transplantation.
Chemotherapy.
Biological immunosuppression.
Treatment for haematological malignancy.
In urgent situations where immunosuppression cannot wait, some clinicians treat empirically if the risk is significant. This decision should involve infectious diseases or tropical medicine specialists.
Follow-up after treatment
Follow-up depends on how the diagnosis was made.
If stool, sputum, or tissue was positive, repeat parasitology can help confirm clearance. If serology was the main diagnostic test, falling titres over time support response, but interpretation is not immediate.
Recurrent eosinophilia or symptoms after treatment should prompt reassessment. Reinfection is possible with ongoing exposure, and treatment failure can occur, especially in immunocompromised hosts.
How to approach an FRCPath Part 2 scenario
Part 2 questions often test prioritisation. The answer should move from recognition to risk assessment, then to tests and communication.
Scenario pattern one is eosinophilia in a traveller or migrant
A common stem describes a patient with eosinophilia and vague gastrointestinal symptoms, with a history of residence in Southeast Asia, sub-Saharan Africa, Latin America, the Caribbean, or another endemic area.
A strong answer includes:
Ask about travel, residence, sanitation, barefoot soil exposure, and prior treatment.
Request Strongyloides serology and stool examination for ova, cysts, and parasites with specific request for larvae.
Send multiple stool samples if suspicion remains.
Consider other causes of eosinophilia, including schistosomiasis, filariasis, hookworm, allergy, drugs, and haematological disease.
Treat confirmed infection, usually with ivermectin.
Scenario pattern two is steroids followed by sepsis and respiratory failure
This is the classic severe case. The stem may include asthma, COPD, autoimmune disease, lymphoma, or transplant. The patient receives steroids and then develops pneumonia, diarrhoea, Gram-negative bacteraemia, or meningitis.
A high-scoring answer should state:
Suspect hyperinfection.
Examine stool and sputum or bronchoalveolar lavage for larvae.
Inform the clinical team urgently if larvae are seen.
Start ivermectin urgently with expert advice.
Treat bacterial sepsis.
Reduce immunosuppression if possible.
Consider HTLV-1 testing where epidemiologically appropriate.
Scenario pattern three is transplant screening
The question may involve a donor or recipient with previous residence in an endemic region. The exam may ask what to do before transplantation or immunosuppression.
Include:
Risk assessment based on lifetime exposure, not just recent travel.
Serology as a screening tool.
Stool testing if symptomatic or serology positive.
Treatment before immunosuppression when possible.
Communication between microbiology, transplant, infectious diseases, and the laboratory.
Scenario pattern four is larvae seen unexpectedly
Sometimes the laboratory finds motile larvae in stool or respiratory samples.
The answer should include:
Identify likely S. stercoralis, supported by morphology and clinical context.
Consider hookworm in the differential, especially if stool is old.
Alert the clinical team, especially if the specimen is respiratory or the patient is immunosuppressed.
Recommend urgent assessment for hyperinfection.
Ensure appropriate specimen handling and referral if confirmation is needed.
Common exam questions and model answer points
Explain the life cycle
Mention skin penetration by filariform larvae, blood spread to lungs, ascent and swallowing, adult females in small bowel mucosa, rhabditiform larvae in stool, environmental development, and autoinfection.
The exam-winning phrase is autoinfection permits lifelong infection and severe disease under immunosuppression.
Why is eosinophilia not reliable?
Eosinophilia may be intermittent in chronic infection and absent in hyperinfection, especially during corticosteroid therapy. A normal count does not rule out infection.
What is the best diagnostic test?
There is no single best test for every situation.
Chronic screening Serology is often useful.
Active intestinal infection Multiple stool examinations, concentration, Baermann, agar culture, or PCR where available.
Hyperinfection Direct detection of larvae in stool, sputum, bronchoalveolar lavage, gastric aspirate, duodenal sample, or tissue.
A good answer links the test to the syndrome.
Why do patients get Gram-negative sepsis?
Migrating larvae can carry enteric bacteria across the intestinal mucosa and into the bloodstream. This can cause bacteraemia, pneumonia, meningitis, or septic shock. Treatment must cover both the parasite and bacterial complications.
What is first-line treatment?
Ivermectin is first-line in most cases. Albendazole is an alternative but is generally less effective. Hyperinfection needs urgent expert management, prolonged or repeated therapy, monitoring for clearance, and attention to absorption.
What makes corticosteroids so dangerous?
Steroids impair host control and can precipitate rapid expansion of the autoinfective cycle. Severe disease can develop even when infection was previously silent.
Study tips for FRCPath success
Strongyloides is not a topic to memorise as isolated facts. Build an answer framework that works under exam pressure.
Learn the life cycle as a clinical story
A useful sequence is:
Infective filariform larvae in soil penetrate skin.
Larvae migrate via blood to lungs.
They ascend the airway and are swallowed.
Adult females live in small bowel mucosa.
Eggs hatch internally, producing rhabditiform larvae.
Larvae pass in stool or become infective within the host.
Autoinfection allows persistence and hyperinfection.
If this sequence is secure, most questions become easier.
Pair each syndrome with the right specimen
Clinical setting | Best specimens or tests to mention |
Asymptomatic risk before immunosuppression | Serology, stool if positive or symptomatic |
Chronic gastrointestinal symptoms with eosinophilia | Serology plus multiple stool samples |
Severe pneumonia after steroids | Sputum or bronchoalveolar lavage plus stool |
Gram-negative meningitis with travel history | Stool, respiratory samples if relevant, serology as support |
Possible donor-derived infection | Donor and recipient risk review, serology, specialist testing |
Practise concise laboratory advice
In Part 2, answers often need a microbiologist’s response, not a textbook essay. Practise wording such as:
“The finding of larvae in sputum in an immunosuppressed patient is concerning for hyperinfection. I would urgently inform the treating team, recommend ivermectin with infectious diseases or tropical medicine input, assess for Gram-negative sepsis, and examine stool and respiratory samples for clearance.”
That style shows clinical relevance and safety.
Do not over-rely on stool microscopy
A single stool microscopy result has limited sensitivity in chronic infection. If the pre-test probability is high, recommend serology and repeated or enhanced stool methods.
Remember HTLV-1
HTLV-1 is a recognised risk factor for severe and recurrent strongyloid infection. It is a useful point in patients from endemic regions or with unexplained severe disease.
Use comparison organisms to sharpen recall
The main differentials in exam answers include:
Hookworm, due to skin penetration, anaemia, and larvae if stool is old.
Ascaris, due to lung migration, but no autoinfection.
Schistosomiasis, due to eosinophilia and tropical exposure.
Filariasis, due to eosinophilia and travel history.
Allergic or drug-related eosinophilia.
The unique discriminator is autoinfection.
Key takeaways for rapid revision
Infective stage Filariform larva.
Diagnostic stool stage Rhabditiform larva, not usually eggs.
Main acquisition route Skin penetration from contaminated soil.
Defining biological feature Autoinfection.
Major severe risk factor Corticosteroid therapy, with HTLV-1 and transplantation also important.
Most useful chronic screening test Serology, interpreted with exposure history and local test performance.
Severe disease specimens Stool, sputum, bronchoalveolar lavage, gastric or duodenal samples, and tissue if involved.
First-line treatment Ivermectin, with expert input for hyperinfection or dissemination.
Dangerous complication Gram-negative sepsis or meningitis due to bacterial translocation with larvae.
Exam trap Absence of eosinophilia does not exclude severe infection.
Strongyloid infection is a classic Part 2 topic because it rewards integrated thinking. The safest answers connect parasite biology to clinical risk: autoinfection explains chronic carriage, chronic carriage explains late presentation, and immunosuppression explains hyperinfection. If that chain is clear, the diagnosis, treatment, and communication points follow naturally.
Comments